{"id":491,"date":"2025-09-19T13:30:07","date_gmt":"2025-09-19T13:30:07","guid":{"rendered":"https:\/\/wickedsister.evit.com.au\/index.php\/2025\/09\/19\/in-ms-less-frequent-treatment-dosing-schedule-is-equally-effective\/"},"modified":"2025-09-19T13:30:07","modified_gmt":"2025-09-19T13:30:07","slug":"in-ms-less-frequent-treatment-dosing-schedule-is-equally-effective","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2025\/09\/19\/in-ms-less-frequent-treatment-dosing-schedule-is-equally-effective\/","title":{"rendered":"In MS, less frequent treatment dosing schedule is equally effective"},"content":{"rendered":"<p><a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2025\/09\/19\/less-frequent-dosing-schedule-ms-anti-cd20-therapies-found-equally-effective\/\" title=\"In MS, less frequent treatment dosing schedule is equally effective\" rel=\"nofollow\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"400\" src=\"https:\/\/multiplesclerosisnewstoday.com\/wp-content\/uploads\/2024\/09\/MedicineChoice-800x400.png\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"A person wearing overalls is seen choosing between two medicines, with an oral capsule hovering over one outstretched hand and a syringe over the other.\" style=\"margin: auto;margin-bottom: 15px;max-width: 100%\" data-wp-pid=\"142496\" \/><\/a><\/p>\n<p>People with multiple sclerosis (MS) may receive less frequent treatments with anti-CD20 therapies without increasing their risk of disease activity or disability progression. That&#8217;s according to a new meta-analysis of [&#8230;]<\/p>\n<p>The post <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2025\/09\/19\/less-frequent-dosing-schedule-ms-anti-cd20-therapies-found-equally-effective\/\">In MS, less frequent treatment dosing schedule is equally effective<\/a> appeared first on <a href=\"https:\/\/multiplesclerosisnewstoday.com\">Multiple Sclerosis News Today<\/a>.<\/p>\n<p><em>Source: <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2025\/09\/19\/less-frequent-dosing-schedule-ms-anti-cd20-therapies-found-equally-effective\/\" rel=\"nofollow noopener\" target=\"_blank\">multiplesclerosisnewstoday.com<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>People with multiple sclerosis (MS) may receive less frequent treatments with anti-CD20 therapies without increasing their risk of disease activity or disability progression. That&#8217;s according to a new meta-analysis of [&#8230;] The post In MS, less frequent treatment dosing schedule is equally effective appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com<\/p>\n","protected":false},"author":0,"featured_media":492,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[11,15,9,8,13,14,12,10],"class_list":["post-491","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis-research","tag-brain-repair","tag-marburg-type-ms","tag-ms","tag-multiple-sclerosis","tag-myelin","tag-neuroregeneration","tag-oligodendrocyte","tag-remyelination"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/491","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=491"}],"version-history":[{"count":0,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/491\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media\/492"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=491"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=491"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=491"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}